NEW YORK (GenomeWeb News) – The UK’s Institute of Cancer Research will use Thermo Fisher Scientific’s proteomics technologies in an integrative network biology initiative, the company said today.

ICR will use Thermo’s TSQ Vantage triple quadrupole system, the Kingfisher Flex sample prep system, two LTQ Orbitrap Velos mass spectrometers, and other technologies, the company said.

The agreement includes lab equipment, protein reagents, mass spectrometry, RNA silencing, and related services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.